{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:06:09Z","timestamp":1778094369152,"version":"3.51.4"},"reference-count":122,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Amyloidosis is an infiltrative disease that may cause cardiomyopathy if the precursor protein that misfolds and forms the amyloid is transthyretic or plasma abnormal light chains. Transthyretin amyloid cardiomyopathy has to be diagnosed timely and accurately since there are specific treatment options to support the patients. Multimodality imaging including electrocardiography, echocardiography with strain imaging and cardiac magnetic resonance applying late gadolinium enhancement imaging, native T1 mapping and extracellular volume, raise a high suspicion of the disease and bone scintigraphy set the diagnosis even without the need of biopsy. However, the morbidity and mortality remain high and the need for risk stratification and assessment of the response to treatment are of paramount importance. Cardiac imaging biomarkers offer a thoughtful insight into the prognosis of these patients at diagnosis and after treatment. The current narrative review aims to enlighten the use of multimodality cardiac imaging in transthyretic amyloid cardiomyopathy throughout the disease pathogenesis and evolution from diagnosis to prognosis and response to treatment in a personalized manner.<\/jats:p>","DOI":"10.3390\/jcm14062014","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:29:28Z","timestamp":1742185768000},"page":"2014","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging"],"prefix":"10.3390","volume":"14","author":[{"given":"Georgios","family":"Tziomalos","sequence":"first","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5724-6798","authenticated-orcid":false,"given":"Thomas","family":"Zegkos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftheria","family":"Baltagianni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-9039","authenticated-orcid":false,"given":"Maria-Anna","family":"Bazmpani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Exadaktylou","sequence":"additional","affiliation":[{"name":"Laboratory of Nuclear Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Parcharidou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-9813","authenticated-orcid":false,"given":"Thomas","family":"Gossios","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argyrios","family":"Doumas","sequence":"additional","affiliation":[{"name":"Laboratory of Nuclear Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-5273","authenticated-orcid":false,"given":"Theodoros","family":"Karamitsos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-9170","authenticated-orcid":false,"given":"Vassilios","family":"Vassilikos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ippokrateio Hospital, School of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Efthimiadis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Ziakas","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8424-6718","authenticated-orcid":false,"given":"Vasileios","family":"Kamperidis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic Amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and Treatment of Cardiac Amyloidosis: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Rapezzi","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of Cardiac Amyloidosis\u2013Associated Heart Failure Hospitalizations among Fee-for-Service Medicare Beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid Nomenclature 2022: Update, Novel Proteins, and Recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac Amyloidosis Due to Transthyretin Protein","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and Treatment of Cardiac Amyloidosis","volume":"12","author":"Gertz","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ajh.27177","article-title":"Immunoglobulin Light Chain Amyloidosis: 2024 Update on Diagnosis, Prognosis, and Treatment","volume":"99","author":"Gertz","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1182\/blood-2011-05-355784","article-title":"The Repertoire of \u03bb Light Chains Causing Predominant Amyloid Heart Involvement and Identification of a Preferentially Involved Germline Gene, IGLV1-44","volume":"119","author":"Perfetti","year":"2012","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational Design of Potent Human Transthyretin Amyloid Disease Inhibitors","volume":"7","author":"Klabunde","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1002\/ehf2.13961","article-title":"Prevalence, Characteristics, and Mortality of Patients with Transthyretin Amyloid Cardiomyopathy in the Nordic Countries","volume":"9","author":"Lauppe","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac Amyloidosis","volume":"18","author":"Hawkins","year":"2018","journal-title":"Clin. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2796.2003.01262.x","article-title":"The Systemic Amyloidoses: Clearer Understanding of the Molecular Mechanisms Offers Hope for More Effective Therapies","volume":"255","author":"Merlini","year":"2004","journal-title":"J. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Saito, Y., Nakamura, K., and Ito, H. (2022). Molecular Mechanisms of Cardiac Amyloidosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010025"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Laptseva, N., Rossi, V.A., Sudano, I., Schwotzer, R., Ruschitzka, F., Flammer, A.J., and Duru, F. (2023). Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072581"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jung, M.H., Chang, S., Han, E.J., and Youn, J.C. (2022). Multimodal Imaging and Biomarkers in Cardiac Amyloidosis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030627"},{"key":"ref_19","first-page":"200271","article-title":"Cardiac Amyloidosis Red Flags: What All the Cardiologist Have to Know","volume":"21","author":"Maloberti","year":"2024","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to Early Diagnosis of Cardiac Amyloidosis: Red Flags from Clinical, Laboratory and Imaging Findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"aus dem Siepen, F., and Hansen, T. (2024). Diagnosing AL and ATTR Amyloid Cardiomyopathy: A Multidisciplinary Approach. J. Clin. Med., 13.","DOI":"10.3390\/jcm13195873"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1093\/eurjpc\/zwab127","article-title":"A National Survey on Prevalence of Possible Echocardiographic Red Flags of Amyloid Cardiomyopathy in Consecutive Patients Undergoing Routine Echocardiography: Study Design and Patients Characterization\u2014The First Insight from the AC-TIVE Study","volume":"29","author":"Merlo","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal Tunnel Syndrome and Spinal Canal Stenosis: Harbingers of Transthyretin Amyloid Cardiomyopathy?","volume":"108","author":"Hein","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tcm.2018.06.011","article-title":"Cardiovascular Magnetic Resonance Imaging for Amyloidosis: The State-of-the-Art","volume":"29","author":"Tang","year":"2019","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/eurheartj\/ehad139","article-title":"Tc-99m Labelled Bone Scintigraphy in Suspected Cardiac Amyloidosis","volume":"44","author":"Rauf","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10741-021-10164-z","article-title":"The Genetics of Cardiac Amyloidosis","volume":"27","author":"Arno","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the Management of Cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic Features and Rhythm Disorders in Cardiac Amyloidosis","volume":"34","author":"Martini","year":"2024","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","article-title":"Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value","volume":"4","author":"Cipriani","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Teresi, L., Trimarchi, G., Liotta, P., Restelli, D., Licordari, R., Carciotto, G., Francesco, C., Crea, P., Dattilo, G., and Micari, A. (2024). Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management-A Narrative Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13185588"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical Points for Echocardiography in Cardiac Amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5603\/CJ.a2021.0085","article-title":"Echocardiographic Markers of Cardiac Amyloidosis in Patients with Heart Failure and Left Ventricular Hypertrophy","volume":"30","author":"Polo","year":"2023","journal-title":"Cardiol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.mayocp.2014.01.013","article-title":"Cardiac Amyloidosis without Increased Left Ventricular Wall Thickness","volume":"89","author":"Lee","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Scheel, P.J., Mukherjee, M., Hays, A.G., and Vaishnav, J. (2022). Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.787618"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/VHRM.S295376","article-title":"Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms","volume":"17","author":"Korosoglou","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic Imaging of Cardiac Amyloidosis","volume":"17","author":"Baksi","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Razvi, Y., Patel, R.K., Fontana, M., and Gillmore, J.D. (2021). Cardiac Amyloidosis: A Review of Current Imaging Techniques. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.751293"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10741-019-09776-3","article-title":"Advances in the Diagnosis and Treatment of Transthyretin Amyloidosis with Cardiac Involvement","volume":"24","author":"Rigopoulos","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality Imaging in Cardiac Amyloidosis: A Primer for Cardiologists","volume":"21","author":"Onciul","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rimbas, R.C., Balinisteanu, A., Magda, S.L., Visoiu, S.I., Ciobanu, A.O., Beganu, E., Nicula, A.I., and Vinereanu, D. (2022). New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092360"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10741-023-10332-3","article-title":"Advance of Echocardiography in Cardiac Amyloidosis","volume":"28","author":"Liang","year":"2023","journal-title":"Heart Fail. Rev"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic Stenosis and Transthyretin Cardiac Amyloidosis: The Chicken or the Egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11886-021-01564-6","article-title":"Multimodality Imaging in Cardiac Amyloidosis","volume":"23","author":"Giblin","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/ejhf.1766","article-title":"The Neglected Issue of Cardiac Amyloidosis in Trials on Heart Failure with Preserved Ejection Fraction in the Elderly","volume":"22","author":"Russo","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical Characteristics of Wild-Type Transthyretin Cardiac Amyloidosis: Disproving Myths","volume":"38","author":"Gagliardi","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jcecho.jcecho_112_20","article-title":"Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis","volume":"31","author":"Licordari","year":"2021","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13506129.2016.1194264","article-title":"Prognostic Value of Right Ventricular Systolic Function in Cardiac Amyloidosis","volume":"23","author":"Bodez","year":"2016","journal-title":"Amyloid"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ehjci\/jes009","article-title":"Comparison of Right Ventricular Longitudinal Strain Imaging, Tricuspid Annular Plane Systolic Excursion, and Cardiac Biomarkers for Early Diagnosis of Cardiac Involvement and Risk Stratification in Primary Systematic (AL) Amyloidosis: A 5-Year Cohort Study","volume":"13","author":"Bellavia","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cardfail.2019.08.002","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2\u2014Diagnostic Criteria and Appropriate Utilization","volume":"25","author":"Dorbala","year":"2019","journal-title":"J. Card Fail."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to Image Cardiac Amyloidosis: A Practical Approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","article-title":"Restrictive Cardiomyopathy: Definition and Diagnosis","volume":"43","author":"Rapezzi","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ehjci\/jex034","article-title":"Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI Expert Consensus Document in Collaboration with the \u201cWorking Group on Myocardial and Pericardial Diseases\u201d of the European Society of Cardiology Endorsed by the Indian Academy of Echocardiography","volume":"18","author":"Habib","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102858","DOI":"10.1016\/j.cpcardiol.2024.102858","article-title":"Imaging Modalities in Cardiac Amyloidosis","volume":"49","author":"Bashir","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ehf2.13738","article-title":"Echocardiographic and Clinical Predictors of Cardiac Amyloidosis: Limitations of Apical Sparing","volume":"9","author":"Kyrouac","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e005588","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/CIRCIMAGING.113.000683","article-title":"Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis from Other Causes of Concentric Left Ventricular Hypertrophy","volume":"6","author":"Liu","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.echo.2019.03.005","article-title":"Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis","volume":"32","author":"Sanabria","year":"2019","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcu.23271","article-title":"Multimodality Imaging in Cardiac Amyloidosis: State-of-the-Art Review","volume":"50","author":"Rosa","year":"2022","journal-title":"J. Clin. Ultrasound."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s10741-021-10165-y","article-title":"Echocardiographic Assessment of Cardiac Amyloidosis","volume":"27","author":"Agrawal","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Monte, I.P., Faro, D.C., Trimarchi, G., de Gaetano, F., Campisi, M., Losi, V., Teresi, L., Di Bella, G., Tamburino, C., and de Gregorio, C. (2023). Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060261"},{"key":"ref_61","first-page":"1128","article-title":"Left Atrial Structure and Function in Cardiac Amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/ehf2.15013","article-title":"Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography","volume":"11","author":"Ferkh","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"E014419","DOI":"10.1161\/CIRCIMAGING.122.014419","article-title":"Myocardial Work in Echocardiography","volume":"16","author":"Marzlin","year":"2023","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/jcecho.jcecho_37_24","article-title":"Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review","volume":"34","author":"Trimarchi","year":"2024","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjcard.2023.09.055","article-title":"Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy","volume":"208","author":"Trimarchi","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"de Gregorio, C., Trimarchi, G., Faro, D.C., Poleggi, C., Teresi, L., De Gaetano, F., Zito, C., Lofrumento, F., Koniari, I., and Licordari, R. (2024). Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction. J. Clin. Med., 13.","DOI":"10.20944\/preprints202403.0569.v1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/jcecho.jcecho_16_21","article-title":"Global Left Ventricular Myocardial Work Efficiency in Heart Failure Patients with Cardiac Amyloidosis: Pathophysiological Implications and Role in Differential Diagnosis","volume":"31","author":"Palmiero","year":"2021","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/echo.15681","article-title":"Strain-Derived Myocardial Work in Wild-Type Transthyretin Cardiac Amyloidosis with Aortic Stenosis-Diagnosis and Prognosis","volume":"40","author":"Ladefoged","year":"2023","journal-title":"Echocardiography"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis. A Doppler Echocardiography Study","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40477-023-00789-1","article-title":"Imaging Findings of Right Cardiac Amyloidosis: Impact on Prognosis and Clinical Course","volume":"26","author":"Tana","year":"2023","journal-title":"J. Ultrasound"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)00400-1","article-title":"Right Ventricular Dilation in Primary Amyloidosis: An Independent Predictor of Survival","volume":"80","author":"Patel","year":"1997","journal-title":"Am. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/13506129.2016.1221815","article-title":"Identification of Prognostic Markers in Transthyretin and AL Cardiac Amyloidosis","volume":"23","author":"Damy","year":"2016","journal-title":"Amyloid"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ejhf.2606","article-title":"Progression of Echocardiographic Parameters and Prognosis in Transthyretin Cardiac Amyloidosis","volume":"24","author":"Chacko","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12574-020-00508-3","article-title":"Efficacy of Echocardiography for Differential Diagnosis of Left Ventricular Hypertrophy: Special Focus on Speckle-Tracking Longitudinal Strain","volume":"19","author":"Tanaka","year":"2021","journal-title":"J. Echocardiogr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cjca.2020.01.020","article-title":"Determinants and Prognostic Significance of Serial Right Heart Function Changes in Patients with Cardiac Amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2022.02.048","article-title":"Prognostic Implications of Right Ventricular Systolic Dysfunction in Cardiac Amyloidosis","volume":"173","author":"Tjahjadi","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jcmg.2021.01.016","article-title":"Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients with Cardiac Amyloidosis","volume":"14","author":"Huntjens","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ehjci\/jead318","article-title":"Evolution and Prognostic Value of Left Ventricular Deformation and Myocardial Work Parameters in Transthyretin Amyloid Cardiomyopathy","volume":"25","author":"Antonelli","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Pugliatti, P., Trimarchi, G., Barocelli, F., Pizzino, F., Di Spigno, F., Tedeschi, A., Piccione, M.C., Irrera, P., Aschieri, D., and Niccoli, G. (2024). Advancing Cardiac Amyloidosis Care Through Insights from Cardiopulmonary Exercise Testing. J. Clin. Med., 13.","DOI":"10.3390\/jcm13237285"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert Consensus on the Monitoring of Transthyretin Amyloid Cardiomyopathy","volume":"23","author":"Bengel","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2023.4147","article-title":"Effect of Tafamidis on Cardiac Function in Patients with Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial","volume":"9","author":"Shah","year":"2024","journal-title":"JAMA Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1253\/circj.CJ-22-0683","article-title":"Impact of Tafamidis on Echocardiographic Cardiac Function of Patients with Transthyretin Cardiac Amyloidosis","volume":"87","author":"Ichikawa","year":"2023","journal-title":"Circ. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ehjci\/jeac049","article-title":"Effect of Tafamidis on Global Longitudinal Strain and Myocardial Work in Transthyretin Cardiac Amyloidosis","volume":"23","author":"Giblin","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13506129.2022.2131385","article-title":"Impact of Tafamidis on Myocardial Strain in Transthyretin Amyloid Cardiomyopathy","volume":"30","author":"Rettl","year":"2023","journal-title":"Amyloid"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"101511","DOI":"10.1016\/j.jacadv.2024.101511","article-title":"Effect of Tafamidis on Clinical and Functional Parameters in Transthyretin Amyloid Cardiomyopathy","volume":"4","author":"Kao","year":"2025","journal-title":"JACC Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11897-020-00481-z","article-title":"Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy","volume":"17","author":"Burrage","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Licordari, R., Trimarchi, G., Teresi, L., Restelli, D., Lofrumento, F., Perna, A., Campisi, M., de Gregorio, C., Grimaldi, P., and Calabr\u00f2, D. (2023). Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103481"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Zhao, L., Tian, Z., and Fang, Q. (2016). Diagnostic Accuracy of Cardiovascular Magnetic Resonance for Patients with Suspected Cardiac Amyloidosis: A Systematic Review and Meta-Analysis. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0311-6"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23660","article-title":"Exercise-Based Cardiac Rehabilitation for Chronic Heart Failure: The EXTRAMATCH II Individual Participant Data Meta-Analysis","volume":"23","author":"Taylor","year":"2019","journal-title":"Health Technol Assess"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jmri.24078","article-title":"Markedly Increased Volume of Distribution of Gadolinium in Cardiac Amyloidosis Demonstrated by T1 Mapping","volume":"38","author":"Brooks","year":"2013","journal-title":"J. Magn. Reason. Imaging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and Extracellular Volume in Transthyretin Amyloidosis","volume":"12","author":"Kotecha","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy","volume":"11","author":"Treibel","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/tomography10080097","article-title":"Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-Analysis","volume":"10","author":"Kato","year":"2024","journal-title":"Tomography"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1262","article-title":"World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)","volume":"18","author":"Brito","year":"2023","journal-title":"Glob. Heart"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.jacc.2020.04.022","article-title":"Cardiac Scintigraphy with Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week","volume":"75","author":"Hanna","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1093\/eurjpc\/zwac237","article-title":"Comparison of Different Technetium-99m-Labelled Bone Tracers for Imaging Cardiac Amyloidosis","volume":"30","author":"Porcari","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and Limitations of 3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy in Systemic Amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"102041","DOI":"10.1016\/j.nuclcard.2024.102041","article-title":"American Society of Nuclear Cardiology Quality Metrics for Cardiac Amyloid Radionuclide Imaging","volume":"40","author":"Hage","year":"2024","journal-title":"J. Nucl. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.semnuclmed.2024.05.012","article-title":"Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects","volume":"54","author":"Clerc","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jjcc.2020.07.003","article-title":"Diagnostic Performance of PET for Detection of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis","volume":"76","author":"Kim","year":"2020","journal-title":"J. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic Utility of the Perugini Grading of 99mTc-DPD Scintigraphy in Transthyretin (ATTR) Amyloidosis and Its Relationship with Skeletal Muscle and Soft Tissue Amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients with ATTR Cardiac Amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ehjci\/jeae295","article-title":"Prognostic Implication of DPD Quantification in Transthyretin Cardiac Amyloidosis","volume":"26","author":"Rettl","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial Scanning with Technetium Pyrophosphate (99mTc-PYP) in Advanced ATTR Cardiac Amyloidosis","volume":"23","author":"DeLuca","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2967\/jnumed.122.265352","article-title":"Regression of Myocardial 99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis","volume":"64","author":"Papathanasiou","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative 99mTc-Pyrophosphate Myocardial Uptake: Changes on Transthyretin Stabilization Therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J. Nucl. Cardiol."},{"key":"ref_120","first-page":"216","article-title":"A Novel Quantitative Method for Assessing the Therapeutic Response to Tafamidis Therapy in Patients with Cardiac TTR Amyloidosis. A Preliminary Report","volume":"25","author":"Doumas","year":"2022","journal-title":"Hell. J. Nucl. Med."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Zhao, M., Calabretta, R., Yu, J., Binder, P., Hu, S., Hacker, M., and Li, X. (2022). Nuclear Molecular Imaging of Disease Burden and Response to Treatment for Cardiac Amyloidosis. Biology, 11.","DOI":"10.3390\/biology11101395"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaccas.2020.11.036","article-title":"First Follow-Up of Cardiac Amyloidosis Treated by Tafamidis, Evaluated by Absolute Quantification in Bone Scintigraphy","volume":"3","author":"Bellevre","year":"2021","journal-title":"JACC Case Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/2014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:54:35Z","timestamp":1760028875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/2014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":122,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14062014"],"URL":"https:\/\/doi.org\/10.3390\/jcm14062014","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,16]]}}}